•  

University of Toronto

Johnson & Johnson Innovation Opens JLABS @ Toronto

TORONTO (May 11, 2016) –  Johnson & Johnson Innovation LLC, today announced the opening of JLABS @ Toronto, a new 40,000-square-foot life sciences incubator, providing entrepreneurs shared lab space and offices, modular lab suites and access to scientific, industry and capital funding experts as they work to build important and successful early-stage companies. The new JLABS facility can accommodate up to 50 start-ups and opens with 22 companies that represent a range of sectors including therapeutics, medical devices and consumer health ... Read more

UTEST program announces investments in five U of T start-ups

Companies in fourth cohort developing products ranging from software to therapeutic platforms; applications for fifth cohort, in partnership with MLA48, open until May 27, 2016 TORONTO (May 9, 2016) — The University of Toronto Early-Stage Technology (UTEST) incubator, co-directed by U of T’s Innovations & Partnerships Office (IPO) and MaRS Innovation with financial support from the Connaught Fund, has announced five investments in start-up companies from Cohort 4. The five companies and the diverse sectors they target are: Ardra Bio, which is ... Read more

TrendMD graduates from Ycombinator and announces new partnerships

It’s been a busy quarter for UTEST company TrendMD. Fresh off their participation in Ycombinator’s Winter 2016 cohort, which was covered in TechCrunch, the company has announced partnerships with HighWire and Integra. TrendMD, a Canadian start-up company, is a content recommendation engine for scholarly publishers. They work with over 2,000 medical journals by organizing and tailoring information to the appropriate audiences. This functionality creates several opportunities for various researchers to promote their research and clinical practices in their respective fields. TrendMD launched through ... Read more

Miroculus acquires Kapplex to advance diagnostics for complex diseases

Canadian innovation will give patients affordable, non-invasive, accurate test for cancer or infectious diseases; R&D team to remain in Toronto discovery district TORONTO and SAN FRANCISCO (May 3, 2016) — Miroculus, a San Francisco-based biotechnology company specializing in microRNA-based diagnostics, today announced an agreement to acquire Toronto-based Kapplex Inc. The Canadian company’s proprietary Digital Microfluidic (DMF) platform is built upon the research of Dr. Aaron Wheeler, a world-leader in microfluidics research at the University of Toronto. This announcement was covered in GenomeWeb and PeHub. When ... Read more

BioTuesdays features Xagenic and company’s molecular diagnostic beta trials

"Closely-held Xagenic plans to conduct beta studies this year, in advance of a major chlamydia and gonorrhea clinical trial, with its rapid X1 molecular diagnostic testing system in preparation for market launches in Europe and the U.S.," Leonard Zahr wrote in a feature article on Xagenic's product development progress for BioTuesdays on April 19, 2016. Xagenic was founded by University of Toronto Professor Shana Kelley in partnership with MaRS Innovation and U of T's Innovations & Partnerships Office in 2010. The company ... Read more

MI’s Joel Liederman on CanadaAM to talk product development

Joel Liederman, vice-president of Physical Sciences, appeared on CanadaAM April 5, 2016 to talk about how to make a product. The interview is part of CanadaAM's "What's Next" segment on technology and entrepreneurship. He and host Beverly Thomson discussed the process for moving from a napkin to a prototype to a market-ready product, including market testing, prototyping, soliciting more customer feedback, and eventually product launch. "Marketing a product is a lot easier now than it used to be," said Liederman. "In the ... Read more

QD Solar receives $2.55 million from Sustainable Development Technology Canada (SDTC)

TORONTO (March 17, 2016) — QD Solar, a Canadian technology company created by the University of Toronto (U of T) and MaRS Innovation, has received $2.55 million from the Sustainable Development Technology Canada (SDTC). QD Solar’s funding — announced March 4, 2016 in Edmonton, Alberta by the Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development — will galvanize a larger $8.7 million project to revolutionize conventional solar panels that waste a large portion of the available energy in sunlight because ... Read more

The Real Pinocchio Effect

TED speaker’s company is changing the technology of emotion and lie detection   Consumer-facing market research studies require a group of people, a product or service for them to experience, and methodology to collect and analyze their feedback. For companies requesting consumer insight to influence a product’s attributes, packaging or promotion, accurate information can make the difference between success and failure. The catch? The best market research exercises can’t consistently determine when people lie. Well-intentioned subjects may do so to please the interviewer, lie ... Read more

Accel-Rx and BDC Capital make second portfolio investment in ScarX Therapeutics

MaRS Innovation portfolio company completing Phase 1 human clinical trial of drug to prevent dermal scarring VANCOUVER (February 16, 2016) — Accel-Rx Health Sciences Accelerator (Accel-Rx), a Centre of Excellence for the Commercialization of Research (CECR), and its partner BDC Capital today announced their second joint investment in ScarX Therapeutics, a Canadian biotechnology company commercializing innovative treatments for dermal scarring (fibrosis). Accel-Rx and BDC Capital, and other investors including MaRS Innovation, have invested a total of $2 million in ScarX. This investment will ... Read more

Ontario advancing nine medical research projects in cancer, heart disease and sleep apnea to market

Applications for next MSc PoP granting round being accepted until February 25, 2016 TORONTO (January 26, 2016) — Nine Ontario-based medical research projects built on great science with potential for significant economic impact are advancing a step closer to market entry thanks to funding from Ontario Centres of Excellence’s Medical Sciences Proof-of-Principle (MSc PoP) program. The projects range from cancer to heart disease to sleep apnea in children. Applications for the next MSc PoP granting round are open until March 4, 2016. To ... Read more
Page 3 of 1712345...10...Last »